Statement from FDA Commissioner Scott Gottlieb, M.D. on steps toward a new, tailored review framework for artificial intelligence-based medical devices - FDA Press Releases

Statement from FDA Commissioner Scott Gottlieb, M.D. on steps toward a new, tailored review framework for artificial intelligence-based medical devices

from Food and Drug Administration--Press Releases https://ift.tt/2I8bEGE
via IFTTT